Intuitive Surgical Inc (ISRG) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.052x

Based on the latest financial reports, Intuitive Surgical Inc (ISRG) has a cash flow conversion efficiency ratio of 0.052x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($911.90 Million) by net assets ($17.60 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ISRG cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Intuitive Surgical Inc - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Intuitive Surgical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intuitive Surgical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intuitive Surgical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Novo Nordisk A/S
CO:NOVO-B
0.039x
Banco Santander S.A
F:BSDK
0.080x
Pfizer Inc
NYSE:PFE
0.029x
Schneider Electric S.E.
PA:SU
0.202x
Pfizer Inc
SA:PFIZ34
0.029x
Welltower Inc
NYSE:WELL
0.015x
Honeywell International Inc
NASDAQ:HON
0.076x
ALLIANZ SE UNSP.ADR 1/10
F:ALVE
N/A

Annual Cash Flow Conversion Efficiency for Intuitive Surgical Inc (1999–2025)

The table below shows the annual cash flow conversion efficiency of Intuitive Surgical Inc from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see ISRG stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $17.94 Billion $3.03 Billion 0.169x +15.61%
2024-12-31 $16.53 Billion $2.42 Billion 0.146x +7.92%
2023-12-31 $13.40 Billion $1.81 Billion 0.135x +0.92%
2022-12-31 $11.11 Billion $1.49 Billion 0.134x -23.26%
2021-12-31 $11.95 Billion $2.09 Billion 0.175x +14.91%
2020-12-31 $9.76 Billion $1.48 Billion 0.152x -21.13%
2019-12-31 $8.28 Billion $1.60 Billion 0.193x +10.30%
2018-12-31 $6.69 Billion $1.17 Billion 0.175x -27.73%
2017-12-31 $4.73 Billion $1.14 Billion 0.242x +34.07%
2016-12-31 $5.78 Billion $1.04 Billion 0.181x +1.01%
2015-12-31 $4.32 Billion $771.90 Million 0.179x -9.20%
2014-12-31 $3.38 Billion $665.10 Million 0.197x -21.69%
2013-12-31 $3.50 Billion $880.00 Million 0.251x +10.51%
2012-12-31 $3.58 Billion $814.20 Million 0.227x -11.21%
2011-12-31 $2.65 Billion $677.60 Million 0.256x -1.17%
2010-12-31 $2.04 Billion $528.00 Million 0.259x +3.46%
2009-12-31 $1.54 Billion $385.06 Million 0.250x +14.04%
2008-12-31 $1.27 Billion $278.24 Million 0.220x -5.10%
2007-12-31 $888.67 Million $205.69 Million 0.231x +36.70%
2006-12-31 $589.71 Million $99.84 Million 0.169x +5.86%
2005-12-31 $442.59 Million $70.79 Million 0.160x +66.15%
2004-12-31 $314.93 Million $30.32 Million 0.096x +441.89%
2003-12-31 $278.96 Million $-7.85 Million -0.028x +87.33%
2002-12-31 $63.68 Million $-14.15 Million -0.222x +6.24%
2001-12-31 $78.29 Million $-18.55 Million -0.237x -67.92%
2000-12-31 $90.73 Million $-12.80 Million -0.141x +80.32%
1999-12-31 $22.21 Million $-15.93 Million -0.717x --

About Intuitive Surgical Inc

NASDAQ:ISRG USA Medical Instruments & Supplies
Market Cap
$147.71 Billion
Market Cap Rank
#161 Global
#91 in USA
Share Price
$417.07
Change (1 day)
+0.12%
52-Week Range
$402.30 - $592.85
All Time High
$610.45
About

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings… Read more